Clinical Guides
Obstructive Sleep Apnoea: Assessment, Device Therapy and Safety
An India-contextualised educational guide to recognising obstructive sleep apnoea, selecting evidence-based device therapy, and managing driving, medicine and perioperative safety.
MedNext Academy | 12 min read
Obstructive Sleep Apnoea: Assessment, Device Therapy and Safety
An India-contextualised educational guide to recognising obstructive sleep apnoea, selecting evidence-based device therapy, and managing driving, medicine and perioperative safety.
Summary
Obstructive sleep apnoea (OSA) is recurrent narrowing or closure of the upper airway during sleep, causing apnoeas or hypopnoeas, arousal, fragmented sleep and sometimes excessive daytime sleepiness. The important clinical consequence is not snoring alone but impaired alertness, cardiometabolic burden and avoidable safety risk. Current guidelines recommends assessment when a person has at least two compatible features such as snoring, witnessed apnoeas, unrefreshing sleep, waking headache, unexplained sleepiness, choking during sleep or cognitive difficulty. A questionnaire can structure history but cannot diagnose OSA or establish fitness to drive.
Objective sleep testing establishes the diagnosis and severity. Management begins with a realistic discussion of symptoms, job and driving demands, weight and activity where relevant, alcohol excess and sedatives before sleep, nasal or device problems, comorbidity, and patient preference. CPAP or auto-CPAP is the usual device treatment; a mandibular advancement splint is a selected alternative, not a generic snoring gadget. There is no routine drug treatment in this guide for airway obstruction or sleepiness. Do not add sedatives, alcohol or opioids to treat sleep disturbance without considering respiratory depression, alertness and the indication.
A patient with sleepiness that may affect driving must stop driving until symptoms are controlled and follow the applicable licensing law. The cited DVLA rule is UK-specific; in India, advise immediate avoidance of driving or safety-critical work while sleepy and use the current local transport, employer and medicolegal process.
How Common Is It?
OSA is frequently missed because snoring is normalised, people sleep alone, fatigue is attributed to work, or a patient does not describe drowsiness. It occurs across sex, age and body size; obesity is a risk factor, not a diagnostic requirement. current guidelines highlights higher prevalence with overweight or obesity, treatment-resistant hypertension, type 2 diabetes, atrial fibrillation, stroke or transient ischaemic attack, heart failure, moderate or severe asthma, polycystic ovary syndrome, Down syndrome, hypothyroidism and acromegaly. These associations should prompt a sleep history, not automatic CPAP.
Do not quote a foreign prevalence as an Indian national estimate without a representative Indian source. Service frequency also depends on access to sleep studies, dental care, PAP supply and follow-up. In a setting with limited testing, the practical priority is to identify dangerous sleepiness, risk-sensitive occupations, perioperative presentations and people with severe cardiopulmonary disease for earlier assessment. current guidelines prioritises sleep-study access where vigilance and alertness are critical, in preoperative assessment for major surgery, pregnancy and unstable cardiovascular disease.
Symptoms, functioning and test results should be reviewed together. A low Epworth score does not prove safe driving, and a high score alone does not diagnose OSA. Record any drowsy-driving episode, near miss, occupational incident, witnessed apnoea and unintentional sleep episode. These details change urgency and safety advice more than a generic snoring label.
Risk Factors
Ask about weight change, alcohol intake, sedatives before bed, opioid use, smoking, nasal obstruction, pregnancy, family history and craniofacial or neuromuscular disease where relevant. current guidelines specifically includes avoiding alcohol excess and sedatives before sleep in OSA information. This is a safety measure, not a licence to abruptly stop a prescribed benzodiazepine, opioid, antiseizure medicine or psychiatric medicine; withdrawal and substitution need the prescriber’s plan. Alcohol or sedatives can worsen alertness and airway vulnerability, while opioids can suppress ventilatory drive.
Consider interactions with comorbidity. OSA may coexist with obesity hypoventilation, COPD–OSA overlap, atrial fibrillation, hypertension, heart failure, diabetes or stroke. Daytime hypercapnia, resting hypoxaemia, oedema, severe breathlessness or disproportionate somnolence need assessment beyond uncomplicated OSA. Pregnancy needs obstetric and respiratory coordination rather than an untested home-device recommendation. Children require paediatric pathways and are outside this adult guide.
Perioperative risk is a separate risk domain. The CPOC 2025 guide says surgical patients should be screened because undiagnosed OSA increases perioperative complications. SASM states that people with OSA may have increased opioid-related respiratory adverse events and may be at increased risk during propofol procedural sedation. Tell anaesthesia and procedural teams about diagnosed or suspected OSA, current PAP/MAD use, prior airway difficulty and sedative or opioid exposure. Never reassure someone that established OSA makes sedation routine.
Diagnosis
History
Take a sleep history from the patient and, with consent, a bed partner or family member. Ask about loud habitual snoring, witnessed pauses, gasping, choking, nocturia, unrefreshing sleep, morning headache, sleep fragmentation, insomnia, fatigue, unintended sleep and effect on driving, work, study or caring duties. Record alcohol, sedatives, opioids and other medicines; comorbid cardiovascular or respiratory disease; nasal symptoms; weight trajectory; and previous sleep study or device experience. Assess driving directly: distance, vehicle class, drowsiness, near misses and vigilance-critical work.
Examination
Record blood pressure, weight and relevant anthropometry, upper-airway and nasal findings, neck and craniofacial features, cardiopulmonary examination and signs of hypoventilation or heart failure. Examination estimates risk but does not establish severity or safely select a device. Assess urgent alternative explanations for hypersomnolence, including sedating medicines, alcohol, sleep deprivation, depression, neurological illness and central sleep disorders.
Investigations
Current guidelines recommends home respiratory polygraphy for suspected OSAHS, with home oximetry when access is limited; more detailed respiratory polygraphy or polysomnography is considered when results and symptoms conflict or extra monitoring is needed. Use sleep-study results to diagnose and grade disease. Review oxygen desaturation, apnoea–hypopnoea index or equivalent, symptoms and comorbidity together. Do not diagnose solely from a screening score, smartwatch result, snoring recording or oximetry without appropriate clinical interpretation. Check for obesity hypoventilation or overlap syndrome when indicated rather than treating all sleep-disordered breathing as isolated OSA.
Differential Diagnosis
Snoring without OSA, sleep deprivation, insomnia, circadian disruption, restless legs, periodic limb movements, narcolepsy or another central hypersomnolence disorder can produce fatigue or sleepiness. Sedatives, alcohol, opioids, antihistamines and some psychotropic medicines can contribute to sleepiness or hypoventilation. Depression, anaemia, hypothyroidism, chronic pain and cardiopulmonary disease may coexist; do not use a positive questionnaire to end the differential.
Obesity hypoventilation syndrome and COPD–OSA overlap deserve particular attention because ventilation support, blood-gas assessment and referral differ from uncomplicated OSA. Persistent daytime hypercapnia, hypoxaemia, severe dyspnoea or fluid retention requires respiratory evaluation. Nocturnal choking with reflux, epilepsy, panic and cardiac arrhythmia also require clinical context. In children, adenotonsillar and developmental causes require paediatric assessment, not adult CPAP extrapolation.
For perioperative patients, a high screening risk is not a formal diagnosis but should trigger anaesthesia planning, monitoring and referral according to urgency and local capability. For drivers, the question is not merely whether a diagnosis is documented; excessive sleepiness with likely driving impact demands immediate safety advice. UK DVLA reporting requirements are not transferable to India, but the risk of a drowsy-driving crash is. Document the advice, the patient’s response and a prompt route to objective testing.
Management
Offer individualised lifestyle support: weight management when relevant, regular activity, reduced alcohol excess, avoidance of sedatives before sleep where clinically safe, sleep-position or nasal review when appropriate, and treatment of modifiable comorbidity. Lifestyle measures can improve symptoms but should not delay urgent testing or evidence-based device treatment in a sleepy driver or a person with significant OSA. current guidelines says CPAP should be offered for moderate or severe symptomatic OSAHS, and considered for mild symptomatic disease where symptoms affect quality of life and daytime functioning.
The AASM PAP guideline recommends PAP over no therapy for adults with excessive sleepiness and permits initiation using home auto-adjusting PAP or laboratory titration in adults without significant comorbidity. It recommends either CPAP or APAP for ongoing treatment. Support determines success: check mask fit, leak, nasal or mouth dryness, pressure intolerance, sleepiness, device download where available and adherence. A device obtained without diagnostic assessment, education or follow-up is not adequate care.
If CPAP is declined or intolerable, current guidelines considers a customised or semi-customised mandibular advancement splint for adults with optimal dental and periodontal health. AASM/AADSM says a qualified dentist should provide a custom, titratable appliance and that CPAP is generally more effective in improving oxygenation and reducing respiratory-event indices. Arrange dental and sleep follow-up, not an over-the-counter device alone. Consider positional therapy or surgical assessment only through a sleep service for selected disease patterns. There is no invented stimulant, sedative, oxygen or drug substitute in this guide.
Prescribing Information
There is no routine pharmacological treatment in this guide for the anatomical obstruction of OSA. Do not prescribe a sedative, alcohol, opioid or unverified supplement as a substitute for diagnostic testing, CPAP/APAP, a selected MAD or specialist referral. current guidelines explicitly includes avoiding alcohol excess and sedatives before sleep in patient information. This does not mean that prescribed sedatives or opioids should be stopped abruptly: review the indication, dose, timing, co-prescribed respiratory depressants, withdrawal risk and safer alternatives with the responsible clinician.
Opioids require particular caution. SASM concludes that patients with OSA may be at increased risk for opioid-related respiratory events and notes opioids’ ventilatory-drive suppression. It also states that OSA patients may be at increased risk of respiratory events with propofol procedural sedation. These are risk statements, not a dose table. The anaesthetist or acute-pain team must individualise analgesia, monitoring, discharge setting and use of home PAP. Do not give a routine opioid dose, a benzodiazepine dose, an oxygen prescription or a ‘safe’ sedation threshold from this draft.
Wake-promoting medicines, antihypertensives and drugs for comorbid disease are outside first-line OSA airway therapy and require diagnosis-specific specialist review. Before starting or renewing any medicine, ask about daytime sleepiness and driving. Indian availability, CDSCO authorisation, controlled-drug rules, formulary access, renal/hepatic adjustment, pregnancy, interaction risk and monitoring must be verified locally. This guide intentionally supplies no dose, route, frequency or duration for OSA drugs because no India-specific clinically focused schedule was identified.
When to Refer
Refer to a sleep service for objective testing when symptoms suggest OSA, especially with excessive sleepiness, witnessed apnoeas, hypertension, cardiovascular disease, high-risk occupation, pregnancy or a planned major operation. Fast-track where alertness is essential for work or driving, where there is a history of drowsy-driving or near-miss events, or where cardiopulmonary comorbidity makes delay unsafe. Refer urgently for severe sleepiness affecting safety, suspected obesity hypoventilation, awake hypoxaemia or hypercapnia, decompensated heart failure, unstable cardiovascular disease or progressive neurological symptoms.
Refer to dental sleep medicine only after sleep assessment when a mandibular advancement device is being considered; dental and periodontal health matters, and a custom titratable device needs qualified fitting and review. Refer for ENT, maxillofacial or sleep-surgical assessment only after a defined phenotype and non-surgical options are considered. A patient who cannot use CPAP needs troubleshooting and alternative selection, not dismissal for ‘non-compliance’.
For procedures, inform anaesthesia early and refer through the local preoperative pathway. CPOC’s 2025 guide supports screening, referral and coordinated perioperative management rather than last-minute discovery on the theatre list. Share diagnosis or suspicion, sleep-study severity, device and adherence data, comorbidity, previous complications, opioid/sedative exposure and planned procedure. In India, the availability of sleep labs, PAP consumables, trained dental services and monitored beds varies; transfer or defer elective intervention only after a risk-benefit decision by the responsible surgical and anaesthetic team, not by a generic rule.
Red Flags
Immediate safety action is required for sleepiness that has caused, or is likely to cause, unsafe driving, operating machinery or caring for others. The person must not drive while excessively sleepy. GOV.UK says drivers with OSA and excessive sleepiness must not drive until free from sleepiness or symptoms are controlled while strictly following necessary treatment; its notification rule is UK law only. In India, give equivalent immediate no-driving advice and obtain local occupational, licensing or medicolegal advice.
Urgent medical review is needed for confusion, cyanosis, severe breathlessness, awake hypoxaemia, suspected hypercapnia, new chest pain, syncope, decompensated heart failure, acute neurological deficit or an inability to stay awake safely. These may signal more than uncomplicated OSA. A patient using opioids or sedatives with worsening somnolence, shallow breathing or low oxygen saturation needs emergency assessment, particularly after surgery or a procedure.
Before sedation, anaesthesia or inpatient opioid administration, flag OSA or high risk to the treating team. SASM identifies difficult-airway and respiratory-drug concerns, while CPOC highlights increased perioperative complication risk. Do not promise same-day discharge, a particular monitoring level or a medication plan from an educational guide. If PAP is used at home, bring or document the device only as instructed by the receiving facility; perioperative use, oxygen and observation are team decisions.
Indian Clinical Context
No current Indian national OSA device-selection, driving or perioperative drug protocol was identified for this draft. current guidelines, AASM and CPOC sources are explicitly international/UK or US professional guidance and cannot set Indian legal, reimbursement or product policy. They provide clinically focused clinical principles: confirm disease objectively, support CPAP/APAP, select MAD carefully when CPAP is not tolerated, avoid alcohol excess and sedatives before sleep, and plan surgery early.
Access barriers are clinical safety issues. A person may travel far for a sleep study, be unable to replace masks or filters, lack electricity continuity, buy an unvalidated appliance online or face wage loss from multiple visits. Ask about these barriers before declaring therapy failure. Where respiratory polygraphy or PAP follow-up is unavailable, refer to a centre that can diagnose and monitor; do not prescribe unmonitored oxygen, sedatives or empiric opioids. An accessible written plan should include device troubleshooting contacts, return criteria and no-driving advice if sleepy.
Indian transport and employment law, insurance, employer policy and medicolegal duties must be checked locally. Do not cite DVLA reporting, UK PAP funding or CPOC service arrangements as Indian requirements. The guide is reviewed and has been reviewed by the MedNext Clinical Team by MedNext Clinical Team. It is a learning resource, not a fitness-to-drive certificate, anaesthetic clearance, device prescription or legal opinion.
NMC Competency Mapping
The learner should recognise OSA from a structured sleep history, identify excessive sleepiness and occupational risk, assess common comorbidity, and distinguish diagnostic screening from objective confirmation. Under supervision, they should document snoring, witnessed apnoea, unrefreshing sleep, drowsy driving, medicines and alcohol, perform focused examination, interpret a sleep-study report with clinical context and refer appropriately. They should not certify driving fitness from a questionnaire or a single AHI figure.
Management competence includes counselling on device adherence, explaining CPAP/APAP and custom MAD selection, recognising that CPAP generally has stronger physiological efficacy, and identifying when dental, sleep, respiratory, ENT, anaesthetic or emergency input is required. Pharmacological safety includes avoiding invented OSA medicines, recognising sedative/opioid respiratory risk, and escalating perioperative concerns. Learners must not independently set PAP pressure, prescribe respiratory-depressant medicines for sleep, or give perioperative discharge advice outside supervision and local protocol.
The NMC 2024 curriculum is an educational framework and does not provide OSA drug doses or Indian driving law. Exact competency codes must come from the institution’s current mapping ledger. Suitable assessment includes an OSCE on a sleepy commercial driver, interpretation of a respiratory polygraphy report, CPAP troubleshooting counselling and an anaesthesia handover for suspected OSA.
Key Exam Pearls for NEET PG
Think OSA when at least two features include snoring, witnessed apnoeas, unrefreshing sleep, choking, waking headache, nocturia, unexplained sleepiness, insomnia or cognitive symptoms. Obesity is common but not mandatory. A screening score assists history; objective sleep testing confirms diagnosis and severity. Assess for obesity hypoventilation and COPD overlap where symptoms or blood gases suggest them.
CPAP/APAP is device therapy, not a sedative. AASM supports PAP for adults with excessive sleepiness and either CPAP or APAP for continuing treatment. Custom titratable MAD is an alternative for selected adults who cannot tolerate or prefer not to use CPAP, with dental assessment and sleep follow-up. CPAP generally improves oxygenation and respiratory-event indices more effectively than oral appliances.
Excessive sleepiness and driving is a safety emergency: do not drive until controlled. Avoid alcohol excess and sedatives before sleep where safe. OSA increases concern with opioids and propofol sedation; alert anaesthesia before procedures. There is no routine pharmacological cure in this guide. In India, verify device availability, licensing, transport law and perioperative policy locally.
Frequently Asked Questions
Can a snoring recording or questionnaire diagnose obstructive sleep apnoea?
No. Snoring and screening tools identify people who need assessment, but objective sleep testing establishes OSA and its severity. Current guidelines recommends home respiratory polygraphy for suspected OSAHS, with other tests when results and symptoms conflict or additional monitoring is needed. A score cannot replace a safety assessment for driving, a respiratory evaluation for hypoventilation or a specialist review before treatment.
When is a mandibular advancement device appropriate instead of CPAP?
A custom or semi-custom mandibular advancement splint can be considered for selected adults who decline or cannot tolerate CPAP and have suitable dental and periodontal health. AASM/AADSM recommends a qualified dentist and custom titratable appliance. CPAP is generally more effective for oxygenation and respiratory-event reduction, so appliance choice needs shared decision-making, dental review and follow-up sleep assessment rather than an unregulated online device.
Should a sleepy patient with suspected OSA drive to work or a sleep clinic?
No. Excessive sleepiness that may affect driving requires immediate no-driving advice until symptoms are satisfactorily controlled. UK DVLA reporting rules are jurisdiction-specific and cannot be presented as Indian law, but the crash risk is universal. Record the advice, arrange prompt assessment and use local licensing, employer and occupational-health pathways for transport and safety-critical work.
Are sedatives or opioids safe for sleep in someone with OSA?
They require careful indication-specific review, not routine use for sleep. Current guidelines advises avoiding alcohol excess and sedatives before sleep, and SASM says OSA may increase opioid-related respiratory risk and procedural-sedation respiratory events. Do not stop long-term medicines abruptly. The prescriber or anaesthesia team must review dose, timing, other depressants, monitoring, withdrawal risk and alternatives.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic